Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $22 Million - $25.7 Million
-221,915 Reduced 56.5%
170,848 $19.8 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $2.7 Million - $3.15 Million
28,029 Added 7.68%
392,763 $40.4 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $7.19 Million - $7.6 Million
66,985 Added 22.5%
364,734 $39.8 Million
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $127 Million - $231 Million
-2,028,914 Reduced 87.2%
297,749 $33.9 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $123 Million - $177 Million
2,088,635 Added 877.47%
2,326,663 $144 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $11.5 Million - $16.9 Million
-145,260 Reduced 37.9%
238,028 $19 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $43.2 Million - $54.9 Million
-499,815 Reduced 56.6%
383,288 $40.3 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $19.8 Million - $24.1 Million
-201,110 Reduced 18.55%
883,103 $95.2 Million
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $367 - $441
4 Added 0.0%
1,084,213 $119 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $54.1 Million - $60.2 Million
627,338 Added 137.31%
1,084,209 $102 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $22.4 Million - $29.8 Million
312,210 Added 215.82%
456,871 $42.1 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $53 Million - $66.7 Million
-790,942 Reduced 84.54%
144,661 $10.6 Million
Q3 2020

Nov 16, 2020

SELL
$55.23 - $79.93 $26.9 Million - $38.9 Million
-486,371 Reduced 34.2%
935,603 $72.7 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $4.48 Million - $8.46 Million
148,480 Added 11.66%
1,421,974 $79 Million
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $21.1 Million - $32.6 Million
-846,662 Reduced 39.93%
1,273,494 $37.7 Million
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $53.9 Million - $77.7 Million
2,120,156 New
2,120,156 $76.8 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.